- Home
- ORC vs EYPT Comparison
ORC vs EYPT Comparison
Compare ORC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- EYPT
- Stock Information
- Founded
- ORC 2010
- EYPT 1987
- Country
- ORC United States
- EYPT United States
- Employees
- ORC N/A
- EYPT N/A
- Industry
- ORC Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- ORC Real Estate
- EYPT Industrials
- Exchange
- ORC Nasdaq
- EYPT Nasdaq
- Market Cap
- ORC 623.6M
- EYPT 594.5M
- IPO Year
- ORC 2013
- EYPT 2005
- Fundamental
- Price
- ORC $8.02
- EYPT $7.48
- Analyst Decision
- ORC Buy
- EYPT Strong Buy
- Analyst Count
- ORC 2
- EYPT 8
- Target Price
- ORC $9.50
- EYPT $25.71
- AVG Volume (30 Days)
- ORC 2.6M
- EYPT 922.9K
- Earning Date
- ORC 01-30-2025
- EYPT 03-06-2025
- Dividend Yield
- ORC 17.98%
- EYPT N/A
- EPS Growth
- ORC N/A
- EYPT N/A
- EPS
- ORC 1.01
- EYPT N/A
- Revenue
- ORC $75,695,000.00
- EYPT $45,713,000.00
- Revenue This Year
- ORC N/A
- EYPT N/A
- Revenue Next Year
- ORC N/A
- EYPT N/A
- P/E Ratio
- ORC $7.92
- EYPT N/A
- Revenue Growth
- ORC N/A
- EYPT 7.50
- 52 Week Low
- ORC $7.41
- EYPT $6.90
- 52 Week High
- ORC $9.08
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- ORC 58.47
- EYPT 44.49
- Support Level
- ORC $7.47
- EYPT $7.15
- Resistance Level
- ORC $8.03
- EYPT $8.25
- Average True Range (ATR)
- ORC 0.13
- EYPT 0.66
- MACD
- ORC 0.01
- EYPT -0.01
- Stochastic Oscillator
- ORC 95.61
- EYPT 22.01
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.